Questions discussed in this category
Will you recommend this as a first-line agent? Will you use this as monotherapy or only in combination with other agents like duloxetine?
Will you try the sublingual formulation in a patient who has failed the oral formulation, or vice versa?
What tools do you track to assess progress toward these goals?
Would you consider charging a small fee for managing C-2 prescriptions between appointments instead of requiring the patient to come monthly?
27103193602709227116272522709325503199552519921672
Papers discussed in this category
JAMA neurology, 2021 Jun 01
Frontiers in neurology, 2022 Nov 24
American journal of physical medicine & rehabilitation, 2022 Jan 18
Current pain and headache reports, 2024 Jan 26
The Lancet. Neurology, 2010-04
Cephalalgia : an international journal of headache, 2018-05
Headache, 2018-05
Annals of neurology, 2021 Aug 30
Arthritis and rheumatism, 1994-01
Pain medicine (Malden, Mass.), 2025 Jul 08
Arthritis care & research, 2023 Jul 04
Annals of medicine, 2011 Jul 19